These results, together with a previous report demonstrating that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 assist the strategy of focusing on ACKR3 as a novel solution to modulate the opioid process, which could open up new therapeutic avenues for opioid-connected disorders. Publishing this evaluate means https://finnrnevk.blogdal.com/32989905/a-secret-weapon-for-conolidine